by City of Hope National Medical Center Researchers at City of Hope and Translational Genomics Research Institute (TGen) have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws. The study was published today in the journal Science Translational Medicine. Credit: TGenResearchers...
by Karen Zusi-Tran, Broad Institute of MIT and Harvard Credit: Ricardo Job-Reese, Broad Communications A team led by researchers at Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Harvard Medical School has developed a new method to identify thousands of DNA mutations accurately and efficiently in a patient’s blood sample with minimal sequencing....
by Laurie Fickman, University of Houston Credit: Unsplash/CC0 Public Domain When it comes to cancer detection, size matters. Traditional diagnostic imaging cannot detect tumors smaller than a certain size, causing missed opportunities for early detection and treatment. Circulating tumor exosomes are especially small cancer biomarkers and easy to miss. These nanovesicles are composed of molecules that...
RADIOLOGICAL SOCIETY OF NORTH AMERICA IMAGE: IMAGES SHOW SYMPTOMATIC FALSE-NEGATIVE CANCER IN A 73-YEAR-OLD BLACK WOMAN WHO PRESENTED WITH A PALPABLE ABNORMALITY 64 DAYS AFTER NEGATIVE SCREENING MAMMOGRAPHY. CREDIT: RADIOLOGICAL SOCIETY OF NORTH AMERICA OAK BROOK, Ill. (December 4, 2020) – Breast cancer screening with digital breast tomosynthesis (DBT) offers significant advantages over digital mammography,...
Like a spaceship, the complex sugar molecule (coloured) lands exactly on the tumor protein galectin-1, which here looks like a meteorite and is shown in black and white. Galectins are a family of proteins that have become a promising source of cancer research in recent years. A representative thereof is galectin-1. It sits on...
